no long term data
#retatrutide 2025-06-29
mine went up too
unrelated but sat at 2.5 for 9 months rather than climbing and it kept working, so i never went up
genuine question phase 2 doses are published and theyre not far off what people here run, coincidence rather than plan
anyone gone above 2.5 and what changed
research use only
buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely
anyone compared their Medutest purity across two different ERP lots
i went up too fast, got a fortnight of nothing but nausea, and dropped back two steps
energy expenditure isnt something i could feel, though my sleep tracker disagreed with me
is there any long term safety data at all or is it phase 2 and hope
baseline 58
wk 2 61
wk 4 64
wk 6 67
wk 8 66
wk 10 65 (held dose from wk 7)cant feel it honestly
is TRIUMPH the phase 3 programme
how long before people saw the first change at 2
[edited]held at 15 for 16 months and it never plateaued for me, which i cant explain
watching my heart rate
logging rhr daily
settled by month three
held mine ages
does the energy expenditure claim show up as anything you can feel
[edited]is the phase 2 dosing anywhere near what people here run
triple agonist yeah
baseline 58
wk 2 61
wk 4 64
wk 6 67
wk 8 66
wk 10 65 (held dose from wk 7)